Fortis Healthcare Sees Sharp Open Interest Surge Amid Weak Price Action

Open Interest and Volume Dynamics

The latest data reveals that Fortis Healthcare’s open interest (OI) in futures and options contracts jumped by 9,275 contracts, a substantial 44.12% increase compared to the previous session. This rise in OI was accompanied by a total volume of 38,261 contracts traded, indicating heightened activity in the derivatives market. The futures value stood at ₹57,907.88 lakhs, while the options segment contributed a staggering ₹19,649.23 crores in notional value, culminating in a combined derivatives market value of approximately ₹59,671 lakhs.

Such a pronounced increase in open interest alongside robust volume typically suggests fresh positions being established rather than existing ones being squared off. However, the underlying stock’s price action paints a contrasting picture, as Fortis Healthcare’s share price declined by 4.09% on the day, underperforming its hospital sector peers by 2.64% and the broader Sensex by 3.98%. The stock has now recorded three consecutive days of losses, cumulatively falling 6.16%, with an intraday low of ₹841.35 on 25 Sep 2026.

Price Action and Moving Averages

Fortis Healthcare’s price is trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a sustained bearish trend. The narrow intraday trading range of just ₹0.85 and a weighted average price skewed towards the day’s low indicate selling pressure dominating the session. Moreover, the stock opened with a gap down of 4.04%, reflecting negative sentiment from the outset.

Investor participation appears to be waning, with delivery volumes on 24 Sep falling by 33.98% compared to the five-day average, suggesting reduced conviction among long-term holders. Despite this, liquidity remains adequate, with the stock’s average traded value supporting trade sizes up to ₹2.12 crores without significant market impact.

Market Positioning and Potential Directional Bets

The sharp rise in open interest despite falling prices suggests that market participants may be initiating fresh short positions or hedging existing long exposures. The increase in futures open interest to 30,296 contracts, combined with a high notional value in options, points to active positioning around Fortis Healthcare’s near-term price trajectory.

Given the stock’s underperformance relative to its sector and the broader market, it is plausible that traders are betting on further downside or volatility. The fact that the weighted average price is closer to the day’s low reinforces the presence of selling pressure. Additionally, the decline in delivery volumes indicates that long-term investors might be reducing exposure, while short-term traders ramp up activity in the derivatives market.

Fortis Healthcare’s current Mojo Score of 44.0 and a Mojo Grade of Sell, downgraded from Hold on 15 Sep 2026, corroborate the bearish outlook. The mid-cap hospital stock’s market capitalisation stands at ₹63,529.73 crores, but recent technical and fundamental signals suggest caution. The downgrade reflects deteriorating fundamentals or momentum, which may be influencing the surge in open interest as traders position for further weakness.

Sector and Benchmark Comparisons

While Fortis Healthcare declined by 4.09% on 25 Sep, the hospital sector fell by a lesser 1.62%, and the Sensex was nearly flat, down just 0.11%. This relative underperformance highlights company-specific challenges or negative sentiment not shared by the broader sector. Investors should note that the stock’s three-day consecutive fall and gap-down opening are technical red flags, especially when combined with rising derivatives activity.

Such divergence between derivatives market activity and spot price movement often precedes heightened volatility or a directional breakout. Traders and investors should monitor open interest trends closely in the coming sessions to gauge whether the market is building a bearish consensus or preparing for a potential reversal.

Implications for Investors and Traders

Investors should approach Fortis Healthcare with caution given the current technical and derivatives market signals. The surge in open interest amid falling prices typically indicates that new short positions or protective hedges are being established, which could foreshadow further downside or increased volatility.

Long-term holders may consider reassessing their exposure, especially in light of the recent downgrade to a Sell rating and the stock’s failure to hold above key moving averages. Traders, meanwhile, might look for confirmation of directional bias through subsequent open interest and volume patterns, as well as price action around critical support levels near ₹840.

Given the stock’s liquidity profile, active trading is feasible without excessive market impact, but the narrowing price range suggests a consolidation phase that could precede a breakout. Monitoring option open interest and put-call ratios could provide additional clues on market sentiment and potential directional bets.

Conclusion

Fortis Healthcare Ltd’s derivatives market activity on 25 Sep 2026 reveals a notable increase in open interest and volume despite a weakening stock price. This divergence points to a complex repositioning by market participants, likely reflecting bearish sentiment or hedging strategies. The stock’s technical indicators and recent downgrade reinforce a cautious outlook, with investors advised to watch for further developments in open interest and price trends before committing fresh capital.

As the hospital sector continues to navigate macroeconomic and industry-specific challenges, Fortis Healthcare’s performance and market positioning will remain under close scrutiny. The interplay between derivatives activity and spot price movement offers valuable insights into investor psychology and potential future price direction.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →